BioNTech upgraded to buy on high hopes for combined flu/COVID vaccine and oncology pipeline

Bank of America analysts upgraded BioNTech SE stock to buy from hold on Thursday, citing excitement about its mRNA technology and the outlook for a combined flu/COVID vaccine and oncology vaccines tha...